Trials / Sponsors / Medivation, Inc.

Medivation, Inc.

Industry · 14 registered clinical trials.

Status	Trial	Phase	Started
Withdrawn	Efficacy and Safety Study of MDV9300 in Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (DL Lymphoma, Large B-Cell, Diffuse, Primary Mediastinal Large B-cell Lymphoma, Transformed Indolent Lymphoma	Phase 2	2016-12-01
Completed	Safety, Tolerability and Efficacy Study of the Monoclonal Antibody, CT-011, in Patients With Metastatic Melano Melanoma, Malignant Melanoma	Phase 2	2011-11-01
Terminated	An Extension of the CONCERT Protocol (DIM18) Alzheimer's Disease	Phase 3	2010-04-01
Terminated	An Extension of the HORIZON Protocol Evaluating the Safety of Dimebon (Latrepirdine) in Subjects With Huntingt Huntington Disease	Phase 3	2010-02-01
Terminated	A Safety and Efficacy Study Evaluating Dimebon (Latrepirdine) in Patients With Moderate to Severe Alzheimer's Moderate to Severe Alzheimer	Phase 3	2009-10-01
Completed	A Safety and Efficacy Study of Dimebon in Patients With Huntington Disease Huntington Disease	Phase 3	2009-07-01
Completed	Study to Evaluate the Safety, Tolerability and Efficacy of FOLFOX + CT-011 Versus FOLFOX Alone Metastatic Colorectal Cancer	Phase 2	2009-05-01
Completed	Safety and Efficacy Study Evaluating Dimebon in Patients With Mild to Moderate Alzheimer's Disease on Donepezi Alzheimer's Disease	Phase 3	2009-03-01
Completed	Safety and Tolerability of Dimebon in Patients on Memantine, and Memantine Plus Donepezil Alzheimer's Disease	Phase 1	2008-12-01
Completed	A Safety and Efficacy Study of Oral Dimebon in Patients With Mild-To-Moderate Alzheimer's Disease Alzheimer's Disease	Phase 3	2008-05-01
Terminated	Study of Combination Therapy With Dimebon and Donepezil (Aricept) in Patients With Alzheimer's Disease Alzheimer's Disease	Phase 2	2008-04-01
Completed	A Study of the Novel Drug Dimebon in Patients With Huntington's Disease Huntington's Disease	Phase 2	2007-07-01
Completed	Safety Study of the Novel Drug Dimebon to Treat Patients With Huntington's Disease Huntington's Disease	Phase 1 / Phase 2	2006-10-01
Completed	Double-blind, Placebo-controlled Study of Oral Dimebon in Subjects With Mild to Moderate Alzheimer's Disease Alzheimer's Disease	Phase 2	2005-09-01